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Introduction
Persistent shortage of kidney donation from deceased
donors and superior results in living donor kidney trans-
plantation have increased the incentive for living kidney
donation in The Netherlands. The evolution of the surgi-
cal technique from a large lumbotomy to less invasive
operations has reduced discomfort and enhanced recovery
of living donors following donor nephrectomy. In the
past years, two different operative strategies have been
developed and refined. This study focuses on advantages
and disadvantages of both strategies in a randomized
fashion.
Comparison of the mini-open technique with conven-
tional classic open donor nephrectomy has decreased the
need for opioids and promoted a faster recovery [1,2]. In
1995 laparoscopic donor nephrectomy [3] was intro-
duced. This technique also compared favourably to classic
open surgery [4–6]. The presumably less difficult and fas-
ter hand-assisted variant of the full laparoscopic donor
nephrectomy was introduced in 1998 by Wolf [7] and
further popularised living kidney donation. Compared to
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Summary
A randomized controlled trial was designed to compare various outcome vari-
ables of the retroperitoneal mini-open muscle splitting incision (MSI) tech-
nique and the transperitoneal hand-assisted laparoscopic technique (HAL) in
performing living donor nephrectomies. Fifty living kidney donors were ran-
domized to MSI or HAL. Primary endpoint was pain experience scored on a
visual analogue scale (VAS). After MSI living donors indicated lower median
(range) VAS scores at rest than HAL living donors on postoperative day 2.5
[10 (0–44) vs. 15 (0–70), P = 0.043] and day 3 [7 (0–28) vs. 10 (0–91),
P = 0.023] and lower VAS scores while coughing on postoperative day 3 [20
(0–73) vs. 42 (6–86), P = 0.001], day 7 [8 (0–66) vs. 33 (3–76), P < 0.001] and
day 14 [2 (0–17) vs. 12 (0–51), P = 0.009]. The MSI technique also resulted in
reduced morphine requirement, better scores on three domains of the RAND-
36, reduced costs and reduced CRP and IL-6 levels. The HAL technique was
superior in operating time and postoperative decrease of hemoglobin level. The
MSI technique is superior to the HAL technique in performing living donor
nephrectomies with regard to postoperative pain experience. This study
reopens the discussion of the way to go in performing the living donor
nephrectomy.
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the classic open technique the hand-assisted laparoscopic
technique resulted in a quicker and less painful recovery
as well [8]. Two randomized studies have compared
mini-open to the full laparoscopic technique [9,10]. Both
demonstrated increased pain experience after the mini-
open technique. Despite this, the mini-open technique
has advantages due to its retroperitoneal approach. It
does not open spaces to gain access to the kidney and
large mesothelial surfaces are not exposed to surgical
manipulation and pressurized CO2 gas. Furthermore,
absence of a pneumoperitoneum precludes significant he-
modynamic and respiratory side effects [11,12] during the
operation which minimises surgical trauma and enhances
recovery.
For these practical reasons we challenged previous
reports and have performed a randomized controlled trial
comparing the mini-open muscle splitting incision (MSI)
and hand-assisted laparoscopic (HAL) living donor
nephrectomy. In this study, we tested the hypothesis that
the mini-open technique was not inferior to the hand-
assisted operation as regards to pain. In addition, we also
investigated the magnitude of surgical injury and repair
using surrogate serum markers in both techniques.
Materials and methods
Study design, endpoints and sample size
This single centre randomized controlled trial compared
two different types of operation in performing a living
donor nephrectomy. The two types of operations were
the MSI and the HAL technique. Postoperative pain was
chosen as the primary end point of this study. A non-
inferiority design was chosen as we had demonstrated
decreased hospital cost in an unpublished retrospective
pilot study using the MSI technique. In case the present
study would be able to show clinical non-inferiority and
confirm cost reduction of MSI compared to HAL tech-
nique, this would lead to the conclusion that the MSI
technique should be the technique of choice.
Postoperative pain was scored both in rest and during
provocation by coughing using the visual analogue scale
[13] (VAS) from 0 (no pain) to 100 (most excruciating
pain). Secondary endpoints of this study included serum
C-reactive protein (CRP) and interleukin 6 (IL-6) as
acute phase proteins. Other secondary endpoints were
several intra-operative variables (operating time, decrease
in hemoglobin), peri-operative complications categorized
by the proposed living donor nephrectomy complication
classification scheme [14], Quality of Life (QOL) assess-
ment using the validated Dutch RAND-36 up to 1 year
after donation [15], total morphine use by means of
patient controlled analgesia (PCA), postoperative use of
oral analgesics in the outpatient setting, time interval
until return to work, and short term (8 weeks) outcome
of renal function in the donor (baseline GFR measured
by isotope clearance studies [16]) and the recipient
(serum creatinine up to 3 months postoperative). Donors
were followed up till 1 year after the operation and
checked for hernia and scar healing.
The RAND-36 format included eight dimensions and
one change of general health status in the past year.
Questionnaires were filled in on four occasions: preopera-
tive, 2 weeks, 4 weeks, 8 weeks and 1 year after donor
nephrectomy. Scores for each domain range from 0 to
100 with high scores indicating a good performance.
The cost-effectiveness of MSI versus HAL was assessed by
comparing the difference in cost of both procedures with
the difference in outcome in terms of pain scores. For cost-
effectiveness from the hospital perspective only direct medi-
cal costs were included. For an expanded evaluation, costs
of absence from work were calculated using the friction cost
method. Bootstrap resampling (n = 5000) was performed
to assess uncertainty regarding cost-effectiveness.
In addition to CRP and IL-6 levels at different time
points after the operation, also area-under-the- curves
(AUC’s) of these variables were calculated for a time inte-
grated summary score using the trapezium rule [17].
At the time of design of this study only one report
could be used as reference material [18] for SD of pain
VAS scores in this setting. Reports did show that a VAS
difference of 16 is clinically relevant [19,20]. The sample
size was calculated using a free power and sample size
software program [21]. The calculation was based on
t-test data analyses for independent variables. The non-
inferiority design of the study necessitated a one-sided
statistical test. Using a power of 0.8, a one sided alpha of
0.05 (=an alpha of 0.1 in two-sided tests), a clinical rele-
vant difference of 16, an SD of 20 and a 1:1 ratio of the
control to the experimental group a sample size of 20 in
each group was calculated. As we estimated to have a
combined drop-out and missing value percentage of 20%
the sample size was set at 50 living donors in the two
arms of this controlled randomized study.
Randomisation, blinding and patients criteria
The study was approved by the institutional review board
and conducted in accordance with the principles of the
2000 Declaration of Helsinki. The trial was registered at
clinicaltrials.gov (NCT00258986). A block randomisation
plan was retrieved online at http://www.randomization.
com. The operating team was informed of the allocated
technique the day before surgery. Patients, researchers and
nursing personnel were blinded for the randomization. All
patients received immediate postoperative coverage of the
abdomen with bandages until discharge. Inclusion and
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exclusion criteria are listed in Table 1. Both left- and right-
sided donor nephrectomies were included.
Statistical analyses
Statistical analyses were made on an intention-to-treat proto-
col. Mann–Whitney U tests and exactly calculated likelihood
ratios were used for continuous and categorical variables,
respectively. Continuous data are given as median (mini-
mum–maximum) values unless stated otherwise. The
primary endpoint (VAS score) was analysed by means of the
T-test (in case the Kolmogorov Smirnov test showed a nor-
mal distribution) or the Mann-Whitney U test if no normal
distribution was found. P values of less than 0.05 were con-
sidered statistically significant. Statistical analyses were
performed with the statistical software package SPSS for
Windows version 15.0 (ª2006, SPSS Inc, Chicago, IL, USA).
Surgical and anaesthetic protocols
Potential living kidney donors had an extensive preopera-
tive work-up including GFR measurement by nuclear
tracers and arterial digital subtraction angiography. The
evening before operation, donors were given a drip of 2 l
normal saline/24 h. The anaesthetic protocol included the
use of Ringer’s Lactate (aiming at a diuresis of 1 ml/kg
bodyweight/hour), sufentanil, propofol (maintenance
TCI-target 2.5) and rocuronium.
The MSI donor nephrectomy was performed using a
10 cm transverse subcostal incision made from the tip of
the 10th rib. Oblique muscles were split, avoiding injury
to intercostal nerves. A table mounted wound retraction
system was installed. The peritoneum was not opened.
Ureter and hilar vessels were identified and the kidney
was relieved from surrounding fat. Successively, the ure-
ter, artery and vein were ligated and cut. After removal of
the kidney the muscles were approximated with inter-
rupted absorbable sutures.
The HAL donor nephrectomy was performed with the
patient in right or left tilt without a table break. Ultracision
(Ethicon Endosurgery, Cincinnati, OH, USA) was used for
intra-abdominal dissection. A transverse suprapubic incision
of 8 cm was made. The fascia was cut in de midline and the
peritoneum opened. The Omniport hand device
(Advanced Surgical Concepts Ltd., Dublin, Ireland) was
inserted. Two 12 mm ports were inserted near the umbilicus
and the left or right lower abdomen, respectively. Another
5 mm port was inserted in epigastrio. CO2 insufflation pres-
sure was maintained at 12 mmHg. The kidney was freed
from surrounding tissues and ureter and hilar vessels were
identified. The ureter and artery were clipped and cut and
the vein was stapled and cut (Autosuture EndoGIA Roticu-
lator 30–2.5). After removal of the kidney the port sites of
12 mm were closed at the fascia level by interrupted absorb-
able sutures. The suprapubic fascia was closed using a run-
ning absorbable suture. In both techniques the skin wounds
were infiltrated with 30 ml of 0.25% bupivacaine and closed
intracutaneously.
Removed kidneys were perfused with UW solution
(ViaSpan, Bristol-Myers Squibb, Park Avenue, NY,
USA), bagged and stored on ice (0–5 C).
All donor nephrectomies in this study were performed
by two consultant surgeons out of a group of four. Previ-
ous exposure of these surgeons to the two techniques had
been at least 20 times of each technique.
Postoperatively, donors started patient controlled analge-
sia (PCA) for pain relief. Morphine bolus injection was set
at 1 mg. Lock out time at the recovery was 5 min and in the
ward 10 min. Maximum dosage of morphine in two hours
time was 20 mg. Paracetamol 1 g q.i.d. was added on the
ward and continued p.r.n. at the time of discharge from the
hospital. After discharge donors were advised to resume
normal activities as soon as they felt comfortable to do so.
Results
Demographics
A total of 53 living donor nephrectomies were performed
in the trial inclusion period (April 2004–December 2005).
The trial flow diagram is shown in Figure 1. Three
donors did not participate because of either poor under-
standing of Dutch language (one) or participation in the
Dutch national living donor cross-over programme
involving another transplant center (two). In Table 2 the
demographic data of the donors and the recipients are
listed. In the MSI group no extension to a standard open
technique was necessary and in the HAL group no con-
version to open surgery occurred.
Perioperative variables
Table 3 presents the values of continuous perioperative
variables. The mean skin to skin operation time was
Table 1. Inclusion and exclusion criteria of living kidney donors for
participation in the trial.
Inclusion criteria – Accepted as living kidney donor by the
local living kidney donor screening protocol
– 18 years of age or older
– Adequate understanding of the Dutch language
– Fit to be operated on by the MSI as well as
the HAL technique
– Signed informed consent
Exclusion criteria – Previous abdominal surgery
– Participation of the Dutch living kidney
donor cross-over programme
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36 min longer in the MSI operation (MSI: 242 min, HAL
206 min). The mean time spent in theatre was 26 min
longer in the MSI operation (MSI: 311 min, HAL:
285 min). No learning curves, as indicated by decreasing
operating times over time, were observed in both MSI
and HAL technique (data not shown). As shown in
Table 3, the decrease of hemoglobin was more pro-
nounced following MSI indicating more blood loss with
the MSI technique.
Pain
In Table 4 results of the VAS score are shown for 11 differ-
ent time intervals including the preoperative measurement.
Measuring the VAS score was done both at rest and while
coughing. At five different measurements (two at rest on
days 2 and 3, three while coughing on days 3, 7 and 14)
the VAS score is significantly lower in the MSI operated
group of patients. The lower pain experience in the MSI
group during hospitalization is confirmed by the reduced
postoperative morphine consumption depicted in Table 3.
Inflammatory markers CRP, IL-6
The serum CRP levels were lower after MSI on all post-
operative days. On the first and second postoperative day
the difference in CRP was statistically significant as well
as the area under the curve of CRP (Table 5). Serum
levels of IL-6, preceding CRP in the pro-inflammatory
cascade, were compared between the two groups as well.
Lost to follow-up (n = 0) 
Discontinued intervention 
(n = 0)
Analysed (n = 25)Analysed (n = 25) 
Lost to follow-up (n = 0) 
Discontinued intervention 
(n = 0) 
Allocated to hand assisted
laparoscopic technique (n = 25) 
♦ Received allocated
intervention (n = 25) 
Allocated to muscle splitting
incision technique (n = 25)  
♦ Received allocated
intervention (n = 25) 
Randomized (n = 50) 
Assessed for eligibility (n = 53) 
Excluded  (n = 3) 
♦Not meeting inclusion 
criteria (n = 3) 





Figure 1 Trial flow diagram.
Table 2. Demographic data of living kidney donors operated on
according to the muscle splitting incision (MSI) technique or the hand
assisted laparoscopic (HAL) technique and their kidney recipients. Cat-




Number of donors 25 25
Male/Female 14/11 10/15
Age in years 52 (23–74) 51 (36–70)
Body mass index 26.0 (20.6–43.7) 25.2 (21.1–31.3)
ASA classification* 1/2 19/6 17/8
Mismatch A and B 2 (0–4) 2 (0–4)
Mismatch DR 1 (0–2) 1 (0–2)
Mismatch total 3 (0–6) 3 (0–6)
Left kidney/right kidney 18/7 22/3
Number of arteries 1/>1 22/3 21/4
Number of veins 1/>1 23/2 24/1
Number of ureters 1/>1 25/0 25/0
Recipient
Male/female 14/11 16/9
Age in years 33 (15–59) 44 (17–72)
Living related Yes/No 15/10 17/8
*ASA classification, American Society of Anesthesiologists classification.
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Twelve hours after the surgery the IL-6 level was lower in
the MSI group compared to the HAL group (Table 5).
The AUC of IL-6 in serum was not significantly different
between the MSI and the HAL technique.
Quality of life
The scores for the eight dimensions of the RAND-36 and
the change of general health status, subdivided in the
HAL and the MSI group, are shown in Fig. 2. Two weeks
after the operation, donors operated with the MSI tech-
nique experienced less ‘pain’, less ‘physical limitation’ and
less ‘change’ of their general health than HAL operated
donors. The interval after the operation to resume work
was not different between MSI and HAL nor were any
cosmetic dissatisfactions recorded (Table 3).
Renal function of donor and recipient
Table 3 shows that no differences were found in the per-
centage residual GFR of donors operated with HAL or
MSI technique at 8 weeks postdonation. The kidney func-
tion in the recipients in the first 3 months, assessed by
creatinine levels in serum, also showed no difference
between kidneys from living donors operated by the HAL
or the MSI technique at any time point (Fig. 3).
Complications
Complications are categorized and displayed in Table 6.
No mortalities were observed among living kidney donors
and recipients. No admissions to an intensive care unit
were indicated. If the operating surgeon felt that blood loss
exceeded the arbitrary ‘normal’ amount it was scored as an
‘excessive bleeding’ complication. No hemodynamic prob-
lems or necessity for blood transfusion during the opera-
tion were seen on any of these occasions. One transfusion
of a unit of red blood cells was given two days postopera-
tively because of symptomatic anemia (MSI). No readmis-
sions occurred and no incisional hernia was found. No
statistical significant differences were observed in the
occurrence of major, moderate, minor and total complica-
tions in living donors between the MSI and the technique.
In the recipients no technical difficulties were encountered
that could directly be attributed to the donor operation.
One renal artery thrombosed shortly after transplantation
requiring a thrombectomy (MSI). The recipient suffered
from delayed graft function and was hemodialysed for sev-
eral weeks. One recipient had recurrence of MPGN in the
transplanted kidney that led to the only graft loss in the
study within 1 year after the transplantation (HAL). In six
recipients, eleven biopsy proven rejection episodes were
recorded, that were successfully treated.
Table 3. Peri-operative variables of donors and recipients following live donor nephrectomy using the muscle splitting incision (MSI) technique or





Operating time in minutes 240 (165–312) 25 210 (145–260) 25 0.001
Time spent in theatre in min 310 (230–395) 25 290 (225–330) 25 0.015
Postoperative percentage decrease of Hb 22 (9–34) 25 17 (9–25) 25 0.001
Total amount of morphine consumption in mg 27 (0–81) 25 50 (5–112) 25 0.006
GFR percentage residual function 8 weeks after kidney donation 62 (45–76) 25 64 (53–78) 23 0.521
Hospital admission time in days starting at day of operation 4 (2–13) 25 4 (3–8) 25 0.245
Direct hospital costs in Euro 14.721 (12.402–20.607) 25 16.348 (14.356–18.466) 25 <0.001
Work resumption in days after the operation 53 (18–188) 14 61(21–351) 18 0.730
Costs of absence from work 7.349 (0–19.885) 25 9.294 (0–19.885) 25 0.344
Total costs 20.597 (12.402–40.492) 25 26.398 (14.862–36.388) 25 0.043
Total length of scars in cm 10.0 (9.0–13.0) 24 14.5 (12.5–17.0) 23 <0.001
Number of donors not satisfied with cosmetic result 1 year after surgery 0 17 1 21 NS
Recipient
1st Warm ischemic time* in min 3 (2–12) 25 4 (2–11) 25 0.130
Cold ischemic time† in min 149 (106–251) 25 151 (89–211) 24 0.212
2nd Warm ischemic time‡ in min 39 (27–146) 25 39 (28–60) 25 0.403
Number of recipients with 1-year graft survival 24 25 25 25 NS
Hb, hemoglobin; GFR, glomerular filtration rate.
*1st Warm ischemic time, time in minutes between occluding the renal artery and the start of cold flush.
†Cold ischemic time, time in minutes between the start of cold flush and the start of suturing the vascular anastomoses.
‡2nd Warm ischemic time, time in minutes between the start of suturing the vascular anastomoses and reperfusion.
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Costs
Direct hospital cost of the living donors was lower with
MSI technique than with HAL technique (Table 3). For
the hospital one MSI operation saved Euro 1.601 com-
pared to one HAL operation, being approximately 10% of
the overall hospital cost of a living kidney donor. The dif-
ference was predominantly caused by the use of more
Table 4. Median (minimum–maximum) visual analogue scale (VAS, range 0–100) scores of living kidney donors at different postoperative time
intervals and conditions following muscle splitting incision (MSI) or hand assisted laparoscopic (HAL) living donor nephrectomy.
MSI HAL
PVAS score N VAS score N
At rest
Day )1 0 (0–0) 25 0 (0–0) 25 1.000
Day 0 18 (0–71) 24 18 (0–68) 25 0.659
Day 1.0 (08.00) 30 (0–64) 25 28 (0–55) 25 0.838
Day 1.5 (18.00) 14 (0–56) 23 14 (0–54) 24 0.468
Day 2.0 (08.00) 18 (0–40) 24 21 (0–65) 23 0.254
Day 2.5 (18.00) 10 (0–44) 20 15 (0–70) 20 0.043
Day 3.0 (08.00) 7 (0–28) 16 10 (0–91) 16 0.023
Day 7 2 (0–19) 25 6 (1–65) 24 0.060
Day 14 1 (0–13) 21 2 (0–20) 22 0.328
Day 28 0 (0–5) 24 0 (0–13) 21 0.514
Day 56 0 (0–11) 25 0 (0–16) 23 0.507
Coughing
Day )1 0 (0–0) 25 0 (0–0) 25 1.000
Day 0 53 (6–89) 24 48 (16–100) 25 0.304
Day 1.0 (08.00) 45 (10–88) 23 61 (17–100) 24 0.077
Day 1.5 (18.00) 37 (15–80) 23 43 (15–90) 22 0.551
Day 2.0 (08.00) 41 (0–71) 23 40 (5–90) 20 0.390
Day 2.5 (18.00) 35 (0–69) 20 40 (9–100) 19 0.238
Day 3.0 (08.00) 20 (0–73) 14 42 (6–86) 16 0.001
Day 7 8 (0–66) 25 33 (3–76) 24 <0.001
Day 14 2 (0–17) 21 12 (0–51) 22 0.009
Day 28 0 (0–8) 24 1 (0–22) 21 0.738
Day 56 0 (0–0) 25 0 (0–18) 23 0.136
Table 5. Serum levels and area under the curves (AUC) values of cold reactive protein (CRP) and interleukin 6 (IL-6) in living donors following
muscle split incision (MSI) or hand assisted laparoscopic (HAL) nephrectomy. For the AUC cases are excluded listwise in case of one or more miss-




CRP day 0 (mg/l) 2 (2–20) 25 2 (2–26) 24 0.200
CRP day 1 (mg/l) 32 (10–88) 24 46 (17–186) 25 0.006
CRP day 2 (mg/l) 76 (24–183) 23 112 (41–283) 24 0.024
CRP day 3 (mg/l) 59 (16–174) 21 82 (29–227) 24 0.080
AUC of CRP, censored for patients with missing values 135 (43–310) 20 213 (80–571) 22 0.025
IL-6, T 0 h (pg/ml) 0 (0–12) 23 0 (0–23) 25 0.912
IL-6, T 4 h (pg/ml) 24 (0–59) 23 27 (11–83) 24 0.132
IL-6, T 12 h (pg/ml) 24 (11–52) 22 33 (16–100) 25 0.011
IL-6, T 24 h (pg/ml) 25 (2–74) 23 28 (14–44) 24 0.519
IL-6, T 48 h (pg/ml) 20 (5–50) 24 19 (7–28) 23 0.765
IL-6, T 72 h (pg/ml) 12 (3–22) 22 13 (3–65) 22 0.519
AUC of IL-6, censored for patients with missing values 58 (19–113) 20 72 (32–109) 20 0.099
AUC, area under the curve; CRP, cold reactive protein; IL-6, interleukin 6.
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expensive disposables amounting to a total of Euro 2.086
for every HAL operation. Cost of absence from work did
not differ significantly between HAL and MSI groups.
When combined with the direct cost, total costs were still
significantly lower for the MSI technique (P = 0.03).
Discussion
This trial compares two different techniques for living
donor nephrectomy: the muscle splitting incision (MSI)
technique and the hand-assisted laparoscopic (HAL) tech-
nique. As regards to the primary endpoint the MSI tech-
nique is superior and associated with less pain than the
HAL technique. In addition, a decreased systemic pro-
inflammatory response and reduction in hospital cost
were found using the minimal open technique. For other
secondary endpoints such as operation time and decrease
in haemoglobin, the HAL technique was superior.
Many of our findings are not in accordance with previ-
ous reports on the same subject that all took the position
of a clear advantage of laparoscopic over open technique.
Differences are discussed in the following paragraphs.
Set up
The study was set up as a single center prospective rando-
mised trial with a non-inferiority design. If the MSI tech-
nique for performing the donor nephrectomy would prove
to be equal or superior to the HAL technique with respect
to clinical outcome, the less expensive MSI operation
should be considered the first choice option. The primary
end point of clinical outcome in this study was the pain
experience measured by means of the VAS score. Several
other variables were included as secondary end points. All
50 living donors who fulfilled the inclusion criteria gave
consent to participate in the trial. This conspicuous find-
ing supports the unbiased nature of information given to
the living donors and contributes to the reliability of the
results. Since no conversions or major intra-operative
complications occurred the two groups of living donors
are homogeneous and very suitable for analyses.
Techniques
The retroperitoneal MSI operation was developed in our
hospital from a standard open technique. With this
Figure 2 Median RAND-36 domain scores of living donors before
and after live donor nephrectomy using the muscle splitting incision
(MSI) technique or the hand assisted laparoscopic (HAL) technique.
*P < 0.05.
Figure 3 Median (interquartile ranges) posttransplantation creatinine
levels in censored recipients (no rejection, no thrombosis, no recurrent
disease in the transplanted kidney) of living donated kidneys using the
muscle splitting incision (MSI) or hand assisted laparoscopic (HAL)
technique.
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technique, great care is taken during dissection of the
required structures in natural planes, saving as much as
possible of the surrounding structures like nerves and
muscles. The transperitoneal HAL technique was adopted
from two hospitals that we visited and who have pub-
lished their technique [8,22].
Perioperative variables
It was remarkable to find that the MSI technique took
36 min longer of skin to skin operative time than the
HAL operation. Antcliffe et al. [23] in a 2009 meta-analy-
sis comparing full laparoscopic to mini-incision found
that the mini-open technique took less operative time
than full laparoscopic techniques. The HAL type of oper-
ation in our center takes about the same time or only
slightly longer than other centers have published [8,22].
The MSI in our study takes more time compared to pub-
lished data on mini-open donor nephrectomy [9,10,24–
27]. No learning curves were found in this study and a
sufficient number of cases of both techniques were per-
formed prior to this study. For this reason we see the
extended operating time in the MSI technique as a reflec-
tion of the patient and careful dissection resulting in pro-
longed operation time.
Blood loss was estimated indirectly through percentage
decrease in hemoglobin level. The decrease of hemoglobin
was higher in the MSI group indicating more blood loss
following this technique compared to the HAL technique.
Nanidis [28] has confirmed the higher amount of blood
loss during open donor nephrectomy compared to the
(hand-assisted) laparoscopic technique in a meta-analysis.
In the present study population the amount of blood loss
did not seem to be clinically relevant in both treatment
arms. Nevertheless, it may be an indication of a techni-
cally more demanding operation when the MSI technique
is applied.
One may speculate that the increased number of reo-
perations in the recipients following an MSI donor opera-
tion (4 vs. 1) may also support the increased difficulty in
the MSI technique. Open key hole surgery may result in
less adequate hemostasis and vascular trauma to the kid-
ney resulting in increased reoperations for bleeding,
thrombosis and ureteral complications in the recipient.
Of course the actual numbers of these complications do
not allow irrevocable conclusions.
Pain
Pain experience is used as one of the major arguments to
promote laparoscopic surgery over open surgery. Chal-
lenging the superiority of the laparoscopic procedure
would only be possible if pain was included as a major
outcome in the set up. Furthermore intense postoperative
pain is a known risk factor for long term adverse out-
come [29]. As postoperative pain score is more intense
and clinically more relevant while coughing [30] the
assessment of pain by means of VAS was done not only
at rest but especially while coughing. In three different
outcome variables involving pain the MSI is superior to
the HAL: lower VAS scores on day 3 to 14 at coughing
and at rest on day 3, less morphine consumption during
admission and lower scores on the pain dimension in the
RAND-36 quality of life questionnaire 2 weeks after sur-
gery. These findings differ from other studies on the sub-
ject as summarized in a recent meta-analysis [23]. Two of
these studies are also randomized controlled trials com-
paring laparoscopic donor nephrectomy to an open
mini-incision technique [9,10,31]. In both trials full
laparoscopic techniques were superior to mini-open tech-
niques with regard to pain outcome, morphine consump-
tion and a number of quality of life items. When we try
to explain the different outcome of our trial, the most
obvious difference is that the ‘hand-assisted’ technique is
used versus ‘full laparoscopy’ in the other two studies.
Table 6. Categorized numbers of complications of living kidney
donation following donor nephrectomy using the muscle splitting inci-




DVT and pulmonary emboli 1
Moderate
Postoperative blood transfusion 1
Minor
Lesion small upperpole artery 1 2
Superficial splenic lesion 2
‘Excessive bleeding’ according to surgeon 3 5
Minor wound infection 2 1
Temporary hypesthesia hand 1
Temporary ipsilateral orchialgia 2
Urinary tract infection 1 1
Temporary bladder dysfunction 1 2
Total number of donor complications 11* 15*
Donor complications, not related to the donor surgery itself
Blister (related to the trial) 2
Recipient complications
Renal artery thrombosis requiring reoperation; DGF 1
Postoperative bleeding requiring reoperation 2
Ureteral stenosis requiring reoperation 1
Re-MPGN and graft loss (explantation) <1 year 1
Rejection episodes in first year, no graft loss 5 6
DVT, deep venous thrombosis; DGF, delayed graft function necessitat-
ing dialysis posttransplantation; MPGN, membranoproliferative glo-
merulonephritis.
*P = NS.
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On the other hand, several other studies have compared
hand-assisted and full laparoscopic techniques for donor
nephrectomy [32,33] and other indications [34,35].
These trials did not show a difference in outcome of
pain and various clinical parameters. A more likely cause
for disparity then may be differences between the type of
mini-open techniques. The increased operating time
using MSI in our trial could confirm such an explana-
tion. Our MSI technique is the ultimate atraumatic
mini-open approach and consumes more time. With
regard to the reduced pain experience of the MSI tech-
nique compared to the HAL technique, it can be
hypothesized that the retroperitoneal access to the kidney
will result in less pain than the transperitoneal HAL
technique due to evasion of many sensory nerve fibers in
the (parietal) peritoneum. Thus, a retroperitoneal HAL
variant, as described by Wadstrom [36], may overcome
this disadvantage.
Systemic immune response
From a pathophysiologic point of view it was of interest
which type of technique evoked the highest acute phase
response as an indication of the amount of inflicted sur-
gical trauma. Acute phase proteins CRP and IL-6 in
serum were used as markers for the total systemic stress
response. These markers have also been used in the past
to support advantages of laparoscopic surgery over open
surgery [37,38]. Levels of CRP and IL-6 have been used
as markers to monitor disease severity and complications
[39]. The lower CRP and IL-6 responses to MSI com-
pared to HAL indicate lower severity of inflicted trauma
by the MSI technique. We suggest that stimuli during the
transperitoneal HAL technique such as pressurized CO2
gas and manipulation of intra-abdominal contents pro-
voke an increased inflammatory reaction. The suppressive
influence of a pneumoperitoneum on hemodynamic and
respiratory variables [40] may also contribute to this phe-
nomenon.
Costs
Hospital costs were Euro 1601 lower for the MSI tech-
nique compared to the HAL operation due to expensive
disposables used for the laparoscopic procedure. These
higher costs of the HAL technique could only partially be
compensated by the shorter time spent in theatre. Many
reports claim the same tendency of increasing hospital
costs following the introduction of the laparoscopic tech-
nique [8,41]. When differences in costs associated with
absence from work, averaging about Euro 2000, were
taken into account, the cost difference further increased
favoring the MSI technique.
Summary and future perspective
This study shows that in our hospital a meticulous retro-
peritoneal MSI technique causes less pain in patients up
to 2 weeks after the operation compared to the transperi-
toneal HAL technique. MSI induces a lower systemic
(pro)inflammatory response and results in less hospital
costs. Arguments against MSI are slightly prolonged oper-
ating time and a modest increased amount of blood loss.
Many of our observations disagree with other studies on
this subject. A possible explanation for this controversy
may be differences in the mini-open technique. We feel
that the approach and results of living donor nephrec-
tomy can still be improved by combining good elements
of the MSI and HAL techniques.
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